Galvus Met 50/100mg In Stock
Anti Diabetes

Galvus Met 50/100mg

Galvus Met 50/1000 mg Tablet is a combination of Vildagliptin (50 mg) and Metformin (1000 mg), used to control high blood sugar levels in patients with Type 2 Diabetes Mellitus. It helps the body use insulin effectively, reduces glucose production in the liver, and improves the body’s response to insulin.

Product Details

**Key Benefits**

  • Helps manage blood sugar levels in adults with Type 2 diabetes.
  • Helps improve blood glucose control by supporting insulin response and reducing excess glucose production.
  • Supports better utilization of glucose by the body.
  • Helps maintain blood sugar levels when used along with diet and exercise.
  • May help reduce the risk of diabetes-related complications when good glucose control is maintained.

**Composition**

  • Vildagliptin – 50 mg
  • Metformin Hydrochloride – 1000 mg

**Recommended Usage**

  • Take as directed by your doctor or healthcare professional.
  • Usually taken once or twice daily with meals, depending on the prescribed regimen.
  • Swallow the tablet whole with water. Do not crush or chew.
  • Take it regularly and do not change the dose without medical advice.

**Safety Information**

  • Inform your doctor if you have kidney or liver problems.
  • Avoid excessive alcohol consumption during treatment.
  • Not intended for Type 1 diabetes or diabetic ketoacidosis.
  • Tell your doctor about other medicines or supplements you are taking.
  • Seek medical advice if you experience persistent weakness, severe stomach discomfort, unusual muscle pain, or other concerning symptoms.

**Possible Side Effects**

  • Nausea or diarrhea
  • Stomach discomfort
  • Headache or dizziness
  • Metallic taste
  • Low blood sugar, particularly when used with certain other diabetes medicines

**Storage**

  • Store below 30°C in a cool, dry place.
  • Protect from direct sunlight and moisture.
  • Keep out of reach of children.

**Disclaimer**

Galvus Met 50/1000 mg Tablet should be used under medical supervision. Do not adjust the dose or stop treatment without consulting your doctor. Individual response may vary depending on the patient's health condition and treatment plan.